Addressing Immunogenicity Challenges to Select the Best Drug Development Candidate, Upcoming Webinar Hosted by Xtalks
Share Article
In this free webinar, the featured speakers will discuss some of the approaches to therapeutic protein immunogenicity risk assessment including the use of in silico tools and different in vitro assays to mitigate risk and design drugs with a better chance of success in the clinic. Through case studies, they will illustrate complementary approaches that can be applied to different classes of proteins, and discuss the application of early design and developability technology to increase the chances of candidate success.
There has been a growing interest over the past decade in developing methods to assess the risk of unwanted immunogenicity during preclinical drug development, with the aim of mitigating the risk during the drug design phase.